Diligence memo · auto-generated · as of July 2, 2026
Endogenex, Inc.
Endogenex, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Endogenex, Inc. operates in Other Health Care, based in PLYMOUTH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Endogenex, Inc. has raised $122M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $70M on 2024-06-13.
Most recent recorded round closed around 2024-06-13.
Valuation (modeled)modeled
Provath models Endogenex, Inc. at approximately $576M (range $253M–$881M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.88× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era. Within the normal band (88% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 3.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Other Health Care peers (5377 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.